When people say they are "taking NAD+," they often mean NMN or NR. Those are smaller building blocks. Cells can turn them into NAD+.
This page explains what human studies found, without the sales pitch. CoreVials NAD+ is for lab research only.
NMN and NR in One Sentence Each
- NR (nicotinamide riboside): a form of vitamin B3 used in many NAD+ trials.
- NMN (nicotinamide mononucleotide): another building block on the path to NAD+.
Both are studied because plain NAD+ is harder to use as a simple oral "boost" in people.
What Studies Agree On
- Short-term safety: In the doses and time windows studied (often weeks to a few months), NR and NMN were usually well tolerated.
- Blood markers: Many trials show NAD+-related levels in blood go up. That means the compound is doing something measurable.
- Health results: Effects on blood pressure, blood sugar, inflammation, strength, or disease symptoms are mixed. Some small studies look promising. Many outcomes show little or no clear benefit.
A 2023 research review said the same thing in fancier words: markers go up, big health wins are not proven yet.
What We Still Do Not Know
- Which option is "best" for a specific goal
- How long people would need to take them
- Whether blood changes match changes in muscle, brain, or other organs
- Long-term safety over years
How This Connects to Catalog NAD+
Lab NAD+ is a research chemical for experiments. Human NMN/NR trials do not turn a research vial into a personal supplement plan.
Start with the basics: what is NAD+? Curious about weight-loss drug talk? Read NAD+ with retatrutide or tirzepatide.
Lab Checklist
COA lookup · storage guide · research compliance
Quick Questions
Is NMN better than NR? We do not have enough head-to-head human outcome data to crown a winner.
Do these trials prove IV NAD+ drips work? No. Different method, different evidence.
Can CoreVials dose this for me? No.
References
- Freeberg, K.A., et al. (2023). Dietary supplementation with NAD+-boosting compounds in humans. Advances in Nutrition. PMC full text
- Endocrine Reviews (2023). NAD+ in aging biology. DOI: 10.1210/endrev/bnad019
- Systematic review context on NAD+ supplementation strategies. ScienceDirect
